Year: 2023

BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document

Written by Customer Service on November 26, 2023. Posted in Public Companies.

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 26th of November 2023 at 6.40 p.m. EET BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL. BBS-Bioactive Bone Substitutes Plc (“BBS” or the “Company”) has announced on 20th of November 2023 that based on authorization granted by the Extraordinary General Meeting on 23rd of October 2023, the Board of Directors of the Company has decided to arrange...

Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023

Written by Customer Service on November 26, 2023. Posted in Public Companies.

– Oral presentation on MCLA-129 in combination with osimertinib as first line therapy, and in previously treated, NSCLC on Sunday, December 3 at 9:40 a.m. SGT – Poster presentation on MCLA-129 in previously treated HNSCC on Saturday, December 2 at 17:50 p.m. SGT – Investor call on Monday, November 27, 2023 8:00 a.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 26, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of two abstracts regarding MCLA-129 on the European Society for Medical Oncology (ESMO) Asia Congress website. The abstracts highlight updated interim clinical data from expansion cohorts in non-small...

Philips showcases world’s first mobile MRI system with helium-free operations at #RSNA23

Written by Customer Service on November 26, 2023. Posted in Public Companies.

Philips Mobile MRI system expanding access to careInterior view of Philips Mobile MRPhilips MR Mobile connected to Philips’ Radiology Operations Command Center (ROCC)November 26, 2023 BlueSeal MR Mobile’s unique magnet technology advances patient outcomes and access to care with high quality diagnostic imaging and enhanced workflows Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today showcases the world’s first mobile MRI system with helium-free operations at #RSNA23. BlueSeal MR Mobile [1], the industry’s first and only 1.5T fully sealed magnet, delivers patient-centric MRI services where and whenever needed. Unlike other mobile MRI scanners, the BlueSeal MR Mobile is more agile and lightweight so it can be located in more convenient...

Updated Notice Regarding Approval of Supplement to Base Prospectus and Amended Summaries

Written by Customer Service on November 26, 2023. Posted in Public Companies.

UAB “Orkela,” legal entity code 304099538, registered address at Jogailos St. 4, Vilnius, Republic of Lithuania (the Issuer), whose securities (the Bonds) are listed and admitted to trading on the Bond List of Nasdaq, also the Bonds are being publicly offered under the base prospectus approved by the Bank of Lithuania on 14 November 2023 (the Prospectus). On 24 November 2023 the Issuer through Nasdaq published a notice “Notice Regarding Approval of Supplement to Prospectus and Amended Summaries“. In order to clarify the information, the notice is updated as follows: The Issuer informs that the first supplement to the Prospectus has been approved by the Bank of Lithuania on 24 November 2023 (the Prospectus’ Supplement), that is attached. Before deciding to invest in the Bonds, please carefully read the Prospectus’ Supplement....

Philips launches new-AI enabled innovations at #RSNA23 that free up healthcare providers to focus on patient care

Written by Customer Service on November 26, 2023. Posted in Public Companies.

Healthcare professional viewing image on MR WorkspacePhilips Mobile MRI system expanding access to careA clinician using next generation EPIQ Elite VM10 with a patientNovember 26, 2023 New innovations help hospitals and health systems to consistently deliver accessible, high-quality care to patients in a sustainable way Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today puts patients and healthcare providers center-stage at #RSNA23, the world’s largest medical imaging conference. Radiologists are looking for solutions to improve the performance of their departments and help patients with optimized workflows, shorter procedure times and user-friendly operations. With 45% of radiologists reporting symptoms of burnout, Philips’ innovations...

BBS-Bioactive Bone Substitutes: The Notified Body has approved the Company’s quality system

Written by Customer Service on November 25, 2023. Posted in Public Companies.

BBS-Bioactive Bone Substitutes Plc, press release, 25 November 2023 at 11.00 a.m. BBS-Bioactive Bone Substitutes Plc (“BBS”) has received confirmation from the Notified Body that the Company’s quality system has received final approval and the official quality certificate has been delivered to the company. BBS previously announced (Company announcement on 2 November 2023) that the approval was expected to be received during November. “With the expected approval of the quality system granted, we can once again mark one important step with regard to the CE marking process completed. The final stage of the process has begun,” says CEO Juliusz Rakowski. After the approval of the quality system, the CE marking of the Company’s first product, ARTEBONE® Paste, only requires final product approval, which is...

Alaska Energy Metals Closes Acquisition of the Angliers-Belleterre Project in Quebec

Written by Customer Service on November 25, 2023. Posted in Mergers And Acquisitions.

Figure 1Claim map on airborne magnetic base map showing potential extension of Midrim nickel – copper deposit host stratigraphy onto Angliers project claims, and elevated nickel in rock samples in northern magnetic belt.Highlights:Alaska Energy Metals Corporation has closed its previously announced acquisition to acquire 100% of the issued and outstanding securities of 1413336 B.C. Ltd., the owner of the Angliers-Belleterre nickel-copper project in western Quebec. The TSX Venture Exchange has granted conditional approval and has granted the Company permission for the completion of this acquisition. The target company’s assets include approximately $2.8 million in cash. The Angliers-Belleterre property is underlain by komatiitic ultramafic flow rocks and differentiated gabbro rocks in a regional setting thought to be a mantle...

Abcourt Announces its Results for the Fourth Quarter and the Year ended June 30, 2023

Written by Customer Service on November 24, 2023. Posted in Earnings Releases And Operating Results.

ROUYN-NORANDA, Quebec, Nov. 24, 2023 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) announces that following the management cease trading order (“MCTO”) issued by the Corporation’s principal regulator, the Autorité des marchés financiers (Québec), on November 1, 2023 and the subsequent news release update issued by the Corporation, Abcourt has completed on November 24, 2023 the filing of its audited consolidated financial statements, its management’s discussion and analysis as well as the CEO and CFO certificates for the year ended June 30, 2023 (collectively, the “Annual Filings”) under its SEDAR+ profile at www.sedarplus.ca and on its website. Consequently, the Corporation expects the MCTO to be revoked by securities regulators in accordance with Policy Statement 12-203 respecting Management...

Etrion Releases Third Quarter 2023 Results

Written by Customer Service on November 24, 2023. Posted in Earnings Releases And Operating Results.

GENEVA, Switzerland, Nov. 24, 2023 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2023. Q3-23 HIGHLIGHTSEtrion closed the third quarter of 2023 with an unrestricted cash balance of US$11.2 million and a positive working capital of US$8.5 million.The Company sold all the solar assets in 2021 and is not developing any new project in 2023. The Company will complete its windup activities and proceed with the dissolution of all the Company’s legal entities. Any cash remaining at the completion of the windup activities and settlement of all liabilities of the Company will be distributed...

Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 9 months of 2023 (unaudited)

Written by Customer Service on November 24, 2023. Posted in Earnings Releases And Operating Results.

Selected Financial Indicators Summarized selected financial indicators of the Group for 9 months of 2023 compared to 9 months of 2022 and 30.09.2023 compared to 31.12.2022 were as follows:in thousands of EUR 09m 2023 09m 2022 ChangeRevenue 46 739 43 974 6.3%Gross Profit 28 078 22 066 27.2%Operating profit 16 267 10 611 53.3%EBITDA 18 630 13 180 41.4%Net profit for the period 8 842 12 516 -29.4%Net profit attributable equity holders of the Parent company 7 912 11 835 -33.1%Earnings per share (EUR) 0,22 0,33 -33.3%Operating cash flow for the period 15 369 12 493 23.0% in thousands of EUR 30.09.2023 31.12.2022 ChangeTotal assets 68 338 63 991 6.8%Total current assets 56 832 50 309 13.0%Total...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals